Anthropic, a prominent artificial intelligence (AI) company, has set up a biology research laboratory in the San Francisco Bay Area to perform hands-on scientific experiments. According to Reuters, Eric Kauderer-Abrams, the company's Head of Life Sciences, confirmed the lab's existence and noted that while Anthropic is conducting experiments internally, it also collaborates with external partners when needed. While Kauderer-Abrams did not disclose specific projects, the company launched a drug discovery initiative called Claude Science earlier this year. A spokesperson clarified that the lab serves broader purposes beyond just drug development. Kauderer-Abrams believes AI can significantly speed up the discovery of treatments for diseases that were once considered too complex to address. He emphasized that AI could help design more precise and effective therapies. According to sources, Anthropic is also exploring ways to use its AI system, Claude, to control robots that perform scientific experiments. However, Kauderer-Abrams noted that the company is still in the early stages of using AI to automate lab tasks, and human supervision remains crucial for safety reasons. Additionally, he mentioned that Anthropic has not yet initiated any clinical trials. In recent developments, Anthropic revealed that it detected and blocked several scientists who were attempting to use its AI models to develop potential biological weapons. The company's CEO, Dario Amodei, has also advocated for a temporary pause in the development of advanced AI systems. His concern is that the rapid advancement of AI could lead to a loss of control over these powerful technologies, posing significant risks to society.